Virtual reality exposure in the treatment of panic disorder and agoraphobia:: A controlled study
Virtual reality exposure in the treatment of panic disorder and agoraphobia:: A controlled study
复制标题
DOI：
10.1002/cpp.524
复制
发表时间：
2007-05-01
影响因子：
3.6
通讯作者：
Riva, G.
中科院分区：
文献类型：
--
作者：
Botella, C.;Garcia-Palacios, A.;Riva, G.
本研究的主要目的是提供有关虚拟现实暴露（VRE）在治疗伴有或不伴有广场恐怖症（PDA）的惊恐障碍中的疗效的数据。该研究是一项受试者间设计，具有三个实验条件（VRE组、体内暴露[IVE]组和等待列表[WL]组）和重复测量（治疗前、治疗后和12个月随访）。治疗方案持续9周。37例符合DSM-IV PDA标准的患者参加了本研究。使用虚拟曝光实现的改善上级WL条件，并且与使用IVE实现的改善相似。我们的研究结果支持VRE治疗PDA的短期和长期疗效。VRE治疗PDA的成本效益问题的优势进行了说明。版权所有（C）2007约翰威利父子有限公司
The main goal of this study was to offer data about the efficacy of virtual reality exposure (VRE) in the treatment of panic disorder with or without agoraphobia (PDA). The study was a between-subject design with three experimental conditions (VRE group, in vivo exposure [IVE] group and waiting-list [WL] group) and repeated measures (pre-treatment, post treatment and 12 month follow-up). The treatment programmes lasted 9 weekly sessions. Thirty-seven patients meeting DSM-IV criteria for PDA participated in this study. The improvement achieved using virtual exposure was superior to a WL condition and similar to that achieved using IVE. Our results support the efficacy of VRE in the treatment of PDA at short and long term. The advantages of VRE for the treatment of PDA regarding cost-benefit issues are described. Copyright (C) 2007 John Wiley & Sons, Ltd.